Literature DB >> 15316805

Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study.

Simon J Hickman1, Ahmed T Toosy, Katherine A Miszkiel, Stephen J Jones, Daniel R Altmann, David G MacManus, Gordon T Plant, Alan J Thompson, David H Miller.   

Abstract

This study reports the prospective follow-up of a cohort of patients with acute optic neuritis examined with serial visual tests, visual evoked potentials (VEPs), conventional and triple-dose gadolinium (Gd)-enhanced magnetic resonance imaging (MRI) to examine which factors are important in visual recovery. Thirty-three patients were recruited with acute unilateral optic neuritis. A clinical and VEP assessment was performed on each. Optic nerve MRI was performed using fast spin echo (FSE) (on all) and triple-dose Gd-enhanced T1-weighted sequences (n = 28). Optic nerve lesion lengths were measured. Serial assessments were performed on 22 of the patients up to one-year. Serial Gd-enhanced optic nerve imaging was performed on 15 of the patients until enhancement ceased. The final 30-2 Humphrey visual field mean deviation (MD) was 2.55 dB higher in patients in the lowest quartile of initial Gd-enhanced lesion length compared with the other quartiles (p < 0.01) but recovery was not related to the duration of enhancement. The initial recovery of Humphrey MD was 4.60 dB units per day in patients with good eventual recoveries (MD > -6.0 dB) and 0.99 dB per day in poor-recovery patients (p = 0.02).Good-recovery patients had mean central field VEP amplitudes 2.29 microV higher during recovery than poor-recovery patients (p = 0.047). The results suggest that factors which are associated with a better prognosis are: having a short acute lesion on triple-dose gadolinium enhanced imaging, higher VEP amplitudes during recovery and a steep gradient of the initial improvement in vision.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316805     DOI: 10.1007/s00415-004-0477-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Visual recovery in patients with optic neuritis and visual loss to no light perception.

Authors:  T L Slamovitis; C E Rosen; K P Cheng; G G Striph
Journal:  Am J Ophthalmol       Date:  1991-02-15       Impact factor: 5.258

2.  A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis.

Authors:  J H Noseworthy; P C O'Brien; T M Petterson; J Weis; L Stevens; W K Peterson; D Sneve; S A Cross; J A Leavitt; R G Auger; B G Weinshenker; D W Dodick; D M Wingerchuk; M Rodriguez
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

3.  Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests.

Authors:  A Ghezzi; V Martinelli; V Torri; M Zaffaroni; M Rodegher; G Comi; A Zibetti; N Canal
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

4.  The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial.

Authors:  R W Beck; P A Cleary; J C Backlund
Journal:  Ophthalmology       Date:  1994-11       Impact factor: 12.079

5.  Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

Authors:  J Grimaud; M Lai; J Thorpe; P Adeleine; L Wang; G J Barker; D L Plummer; P S Tofts; W I McDonald; D H Miller
Journal:  Magn Reson Imaging       Date:  1996       Impact factor: 2.546

6.  The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.

Authors:  B D Youl; G Turano; D H Miller; A D Towell; D G MacManus; S G Moore; S J Jones; G Barrett; B E Kendall; I F Moseley
Journal:  Brain       Date:  1991-12       Impact factor: 13.501

7.  Relative afferent pupillary defects in optic neuritis.

Authors:  T A Cox; H S Thompson; J J Corbett
Journal:  Am J Ophthalmol       Date:  1981-11       Impact factor: 5.258

8.  Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.

Authors:  M Filippi; T Yousry; A Campi; C Kandziora; B Colombo; R Voltz; V Martinelli; S Spuler; S Bressi; G Scotti; G Comi
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

9.  Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study.

Authors:  D J Werring; E T Bullmore; A T Toosy; D H Miller; G J Barker; D G MacManus; M J Brammer; V P Giampietro; A Brusa; P A Brex; I F Moseley; G T Plant; W I McDonald; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

Review 10.  Management of acute optic neuritis.

Authors:  S J Hickman; C M Dalton; D H Miller; G T Plant
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

View more
  25 in total

Review 1.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

2.  Neuroimaging in ophthalmology.

Authors:  James D Kim; Nafiseh Hashemi; Rachel Gelman; Andrew G Lee
Journal:  Saudi J Ophthalmol       Date:  2012-10

3.  Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity.

Authors:  Thomas Jenkins; Olga Ciccarelli; Ahmed Toosy; Katherine Miszkiel; Claudia Wheeler-Kingshott; Daniel Altmann; Laura Mancini; Steve Jones; Gordon Plant; David Miller; Alan Thompson
Journal:  Hum Brain Mapp       Date:  2010-02       Impact factor: 5.038

4.  A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis.

Authors:  Andrew P D Henderson; S A Trip; P G Schlottmann; D R Altmann; D F Garway-Heath; G T Plant; D H Miller
Journal:  J Neurol       Date:  2010-02-09       Impact factor: 4.849

5.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

6.  How Common Is Signal-Intensity Increase in Optic Nerve Segments on 3D Double Inversion Recovery Sequences in Visually Asymptomatic Patients with Multiple Sclerosis?

Authors:  T Sartoretti; E Sartoretti; S Rauch; C Binkert; M Wyss; D Czell; S Sartoretti-Schefer
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-29       Impact factor: 3.825

7.  Sensitivity of orbital magnetic resonance imaging in acute demyelinating optic neuritis.

Authors:  Lulu L C D Bursztyn; Lindsey B De Lott; Myria Petrou; Wayne T Cornblath
Journal:  Can J Ophthalmol       Date:  2018-08-24       Impact factor: 1.882

8.  Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.

Authors:  Michal Laron; Han Cheng; Bin Zhang; Jade S Schiffman; Rosa A Tang; Laura J Frishman
Journal:  Mult Scler       Date:  2009-12-07       Impact factor: 6.312

9.  Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema.

Authors:  Chia-Wen Chiang; Yong Wang; Peng Sun; Tsen-Hsuan Lin; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neuroimage       Date:  2014-07-11       Impact factor: 6.556

Review 10.  The investigation of acute optic neuritis: a review and proposed protocol.

Authors:  Axel Petzold; Mike P Wattjes; Fiona Costello; Jose Flores-Rivera; Clare L Fraser; Kazuo Fujihara; Jacqueline Leavitt; Romain Marignier; Friedemann Paul; Sven Schippling; Christian Sindic; Pablo Villoslada; Brian Weinshenker; Gordon T Plant
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.